Researcher
Lynn Jongen
- Disciplines:Gynaecology and obstetrics, Nursing, Endocrinology and metabolic diseases
Affiliations
- Gynaecological Oncology (Division)
Member
From1 Jun 2014 → 23 Jul 2019
Publications
1 - 10 of 15
- Tumor characteristics and outcome by androgen receptor expression in triple-negative breast cancer patients treated with neo-adjuvant chemotherapy(2019)
Authors: Lynn Jongen, Beppe Floris, Hans Wildiers, Frank Claessens, François Richard, Annouschka Laenen, Christine Desmedt, Kevin Punie, Ann Smeets, Ignace Vergote, et al.
Pages: 699 - 708 - Tamoxifen Pharmacogenetics and Metabolism: Results From the Prospective CYPTAM Study(2019)
Authors: Lynn Jongen, Patrick Neven
Pages: 636 - + - Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor-Positive, HER-2 Negative Breast Cancer(2019)
Authors: Laurence Slembrouck, Siel Olbrecht, Lynn Jongen, Hans Wildiers, Beppe Floris, Erik Van Limbergen, Caroline Weltens, Ann Smeets, Robert Paridaens, Ignace Vergote, et al.
Pages: 165 - 171 - Unexpected Benefit from Alpelisib and Fulvestrant in a Woman with Highly Pre-treated ER-Positive, HER2-Negative PIK3CA Mutant Metastatic Breast Cancer (vol 38, pg 1071, 2018)(2019)
Authors: Griet Hoste, Laurence Slembrouck, Lynn Jongen, Kevin Punie, Tom Matton, Sara Vander Borght, Isabelle Vanden Bempt, Joannes Menten, Hans Wildiers, Beppe Floris, et al.
Pages: 113 - 113 - Identification, clinical-pathological characteristics and treatment outcomes of patients with metastatic breast cancer and somatic human epidermal growth factor receptor 2 (ERBB2) mutations.(2019)
Authors: Lynn Jongen, Beppe Floris, Bram Boeckx, Diether Lambrechts, Sara Vander Borght, Annouschka Laenen, Patrick Neven, Hans Wildiers
Pages: 55 - 63 - Unexpected Benefit from Alpelisib and Fulvestrant in a Woman with Highly Pre-treated ER-Positive, HER2-Negative PIK3CA Mutant Metastatic Breast Cancer(2018)
Authors: Laurence Slembrouck, Lynn Jongen, Kevin Punie, Sara Vander Borght, Isabelle Vanden Bempt, Joannes Menten, Hans Wildiers, Beppe Floris, Patrick Neven
Pages: 1071 - 1075 - Tamoxifen metabolism and efficacy in breast cancer– a prospective multicentre trial(2018)
Authors: Patrick Neven, Lynn Jongen, Diether Lambrechts, Hans Wildiers, Minne Casteels, Sabine Van Huffel, Robert Paridaens, Ignace Vergote, Ben Van Calster
Pages: 1 - 19 - Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium(2017)
Authors: Diether Lambrechts, Lynn Jongen
Pages: 1830 - 1840 - The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients(2016)
Authors: Lieveke Ameye, Lynn Jongen, Beppe Floris, Hans Wildiers, Patrick Neven
Pages: 1471 - 1478 - Genetic variant in the osteoprotegerin gene is associated with aromatase inhibitor-related musculoskeletal toxicity in breast cancer patients(2016)
Authors: Anneleen Lintermans, Kathleen Van Asten, Lynn Jongen, Annouschka Laenen, Johan Verhaeghe, Dirk Vanderschueren, Diether Lambrechts, Patrick Neven
Pages: 31 - 6